Evaluation of Mentha longifolia L on dysmenorrhea pain

Evaluation of Mentha longifolia L. efficacy on decrease of dysmenorrhea pain

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181208041882N8

Enrollment

Registered

2023-10-08

Start date

2018-11-27

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention group: Patients with primary dysmenorrhoea with moderate to severe severity use one capsule of mefenamic acid every 6 hours for up to 3 days. Intervention 2: Intervention

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Women's 15 to 45 years old Moderate to severe dysmenorrhea pain

Exclusion criteria

Exclusion criteria: Patients with mild or secondary dysmenorrhea pain Patients have received one of the NSAID drugs. Hypersensitivity to Mentha longifolia L Pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
Dysmenorrhoea pain. Timepoint: Days 0 and 3. Method of measurement: Visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehrooz Heydari

Yazd University of Medical Sciences

b.heydari@ssu.ac.ir+98 35 3820 3410

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026